700
Views
20
CrossRef citations to date
0
Altmetric
Original Articles

One-pot synthesis and characterization of crosslinked polyphosphazene dopamine microspheres for controlled drug delivery applications

&
Pages 854-859 | Received 06 Jul 2018, Accepted 01 May 2019, Published online: 21 May 2019
 

Abstract

Inorganic–organic hybrid and highly cross-linked poly(cyclotriphosphazene-co-dopamine) microspheres (PCTD) were successfully synthesized by a one-step precipitation polymerization technique. In the polymerization reaction, dopamine (a neurotransmitter), hexachlorocyclotriphosphazene (HCCP, N3P3Cl6) and triethylamine (TEA) were used as a monomer, a crosslinker molecule and an acid acceptor, respectively. The characterization of PCTD microspheres was performed by SEM-EDX, FTIR, XRD, TGA and DLS. The particle size of microspheres were determined as 1.042 µm. The usability of synthesized novel polyphosphazene microspheres for controlled drug release was investigated using acriflavine as a model drug. Acriflavine has antimicrobial and anticancer properties. As drug release medium pH:7.4 (PBS) and pH: 5.0 buffer solutions were used. They were the pH of blood and the approximate pH of the environment in which the cancerous cells are located, respectively. PCTD microspheres have 19.5 mgg−1 drug storage capacity and 29% (pH: 5.0) and 47% (pH: 7.4) of the acriflavine was released from PCTD microspheres at 37 °C during 7 days.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.